Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage

Recruiting Phase 3 Interventional Study
Traumatic Intracranial Haemorrhage
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 3
Study type
Interventional
Purpose
Treatment
Participants needed
1,084 (estimated)
Sponsor
Walton Centre NHS Foundation Trust · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Older people falling from a standing height is the most common cause of hospital admission for head injury. Up to 1 in 3 patients admitted are taking a tablet medication which thins the blood, known as an oral anticoagulant. This type of medication can increase the likelihood of bleeding in the brain. Many patients are taking oral anticoagulation due to having an irregular heartbeat (called atrial…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Informed consent obtained from participant / participants' legal representative and ability to comply with the requirements of the trial 2. Adult ≥18 years with traumatic intracranial haemorrhage (tICrH) in the past 1 week who were taking oral anticoagulants (OAC) prior to ad…
Contacts

Laura Wright

+44(0)151 795 8751

restart.trial@liverpool.ac.uk

CONTACT

Ben Hardwick

+44(0)151 795 8751

restart.trial@liverpool.ac.uk

CONTACT